UBS Group AG - APTEVO THERAPEUTICS INC ownership

APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 27 filers reported holding APTEVO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of APTEVO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$28
-99.2%
85
-94.1%
0.00%
Q4 2022$3,318
+231.8%
1,430
+232.6%
0.00%
Q3 2022$1,000
-75.0%
430
-61.2%
0.00%
Q2 2022$4,000
-84.0%
1,107
-65.5%
0.00%
Q4 2021$25,000
-39.0%
3,212
+76.4%
0.00%
Q2 2021$41,000
+272.7%
1,821
+485.5%
0.00%
Q4 2020$11,000
-83.6%
311
-96.5%
0.00%
Q3 2020$67,000
-19.3%
8,848
-11.7%
0.00%
Q2 2020$83,000
+93.0%
10,015
-13.3%
0.00%
Q1 2020$43,00011,5480.00%
Other shareholders
APTEVO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 1,334,169$440,2760.32%
ARMISTICE CAPITAL, LLC 1,235,000$407,5500.01%
Divergent Wealth Advisors 10,000$3,3000.00%
FIFTH THIRD BANCORP 291$960.00%
FRANKLIN RESOURCES INC 10,997$3,6290.00%
BANK OF AMERICA CORP /DE/ 6$20.00%
PNC FINANCIAL SERVICES GROUP, INC. 142$470.00%
WELLS FARGO & COMPANY/MN 1,562$5150.00%
NORTHERN TRUST CORP 14,121$4,6600.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of APTEVO THERAPEUTICS INC shareholders